REFERENCES
- Carugati A, Olivari A, Pradier R. Six-year follow-up of stages III and IV (MO) head and neck cancer patients with chemotherapy pre-radical treatment. Proc ASCO 1985; 4: 153.
- Wittes R, Heller K, Randolph V. Cis-dichlorodiam-minoplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer. Cancer Treat Rep 1979; 63: 1533–1538.
- Hamasaki VK, Vokes EE. Chemotherapy of head and neck cancer. Curr Opin Oncol 1992; 4 (3), 504–511.
- Palmeri S, Gebbia V, Russo A, Gebbia N, Oliveri D, Rausa L. Cisplatin plus a 5 day continuous infusion of 5 fluo-rouracil in the treatment of locally advanced and metastatic head and neck cancer patients. J Cancer Res Clin Oncol 1989; 115 (6): 579–582.
- Munoz A, Cruz JJ, Pardal JL, et al. Induction chemotherapy with Cisplatin and 5 FU in locally advanced head and neck cancer. Study of 2 administration schedules. Acta Ottorrinolaringol Esp 1991; 42 (2): 111-116.
- Muggia FM, Gibson N. Cisplatin resistance: overview. Ann Oncol 1992; 3(Suppl 1): 117.
- Swinnen LJ, Barnes D, Albain KS, Fisher SG, Fisher RI, Erickson LC. 1 -beta-d-arabinofuranosylcytosine and hydrox-yurea produce cytotoxic synergy with cis-diamminedichloro-platinum and modifications in platinum-induced DNA inter-strand crosslinking. Proc Annu Meet Am Assoc Cancer Res 1988; 29: A1881.
- Kern DH, Morgan CR, Hildebrand-Zanki SU. In vitro pharmacodynamics of 1-beta-d-arabinofuranosylcytosine: syn-ergy of antitumor activity with cis -diamminedichloroplat-inum. Cancer Res 1988; 48 (1): 117–121.
- Oster MW, Schilsky RL, Faraggi D. Cytosine arabi-noside and cisplatin for advanced breast cancer. A phase II study of the cancer and leukemia group B. Cancer 1991; 68 (8): 1696–1698.
- Hudis C, Kelsen D, Dougherty J, Niedzwiecki D, Houston C, Botet J. A randomized trial of streptozotocin, mitomycin and 5-fluorouracil vs cisplatin, ara-c, and caffeine in advanced pancreas cancer. Proc ASCO 1990; 9: A413.
- Margolin K, Doroshow J, Leong L, et al. Combination chemotherapy with cytosine arabinoside and cis-diamminedichloroplatinum for squamous cancer of the upper aerodigestive tract. Am J Clin Oncol 1989; 12 (6): 494–497.
- Ajani J, Roth J, Putnam J. Feasibility of five preopera-tive chemotherapy courses for resectable adenocarcinoma of the esophagus and GE junction. Proc Annu Meet Am Assoc Cancer Res 1992; 33:A1306.
- Milles AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214.
- Crivellari D, Tirelli U, Frustaci S, at al. A phase II study of AMSA in head and neck cancer. Am J Clin Oncol 1987; 10 (1): 23–25.
- Edmonson JH, Frykak S, Letendre L, Kvols LK, Eagen RT. Phase II evaluation of dianydrogalactitol in advanced head and neck carcinomas. Cancer Treat Rep 1979; 68: 2081–2082.
- Felman IE, Grunberg SM. Phase II trial of etoposide (VP-16) in squamous cell carcinoma of the head and neck. Proc ASCO 1983; C–631.
- Shan MK, Engstrom PF, Catalano RB, Paul AR, Bellet RE, Creech RH. Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy. Cancer Treat Rep 1982; 66: 557–558.
- Kaplan BH, Vogl SE, Cinberg J, Berenzweig M, O'Donell M . Phase II trial of vindesine in squamous cancer of the head and neck. Proc ASCO 1982; C–775.
- Basauri LA, Pousa AL, Alba E, Sampedro F. Carboplatin, an active drug in advanced head and neck can-cer. Cancer Treat Rep 1986; 70 (10): 1173–1176.
- Kohno N, Ohnuma T, Biller H, Holland JF. Effects of cisplatin plus 5-fluorouracil vs. DDP plus cytosine arabi-noside on head and neck squamous multicellular tumor spheroids. Proc Ann Meet Am Assoc Cancer Res 1987; 28: 445.
- Powell BL, Craig JB, Muss HB, et al. Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association study. Am J Clin Oncol 1988; 11 (5): 550–552.
- McNulty W, Gonzalez F, McFarland J, Marinkovic M, Valdivieso J. Sequential chemotherapy with hydroxyurea ARA-C, cisplatin and hydroxyurea, 5-fluorouracil for recur-rent squamous cell carcinoma of the head and neck. Proc ASCO 1991; 10:A688.
- Albain KS, Swinnen LJ, Erickson LC, Stiff PJ, Fisher RI. Cisplatin preceded by concurrent cytarabine and hydrox-yurea: A pilot study based on an in vitro model. Cancer Chemother Pharmacol 1990; 27 (1): 33–40.
- Trudeau M, Batist G, Thirlwell M, Boos G, Shennib H, Mulder D. Neoadjuvant chemotherapy with cytosine arabi-noside by continuous infusion and cisplatin for resectable squamous cell carcinoma of the esophagus. J Surg Oncol; 1992; 50 (2): 118–120.